Cardiac monitoring in phase I trials of a novel histone deacetylase (HDAC) inhibitor LAQ824 in patients with advanced solid tumors and hematologic malignancies

被引：0

作者：

Rowinsky, EK

de Bono, J

Deangelo, DJ

van Oosterom, A

Morganroth, J

Laird, GH

Dugan, M

Scott, JW

Ottmann, OG

机构：

[1] Canc Therapy & Res Ctr S Texas, San Antonio, TX 78229 USA

[2] Royal Marsden Hosp, London SW3 6JJ, England

[3] Dana Farber Canc Inst, Boston, MA 02115 USA

[4] Catholic Univ Louvain, B-3000 Louvain, Belgium

[5] Univ PA, Sch Med, Philadelphia, PA USA

[6] Novartis, E Hanover, NJ USA

[7] Univ Frankfurt, D-6000 Frankfurt, Germany

来源：

关键词：

D O I：

暂无

中图分类号：

R73 [肿瘤学];

学科分类号：

100214 ;

摘要：

引用

页码：224S / 224S

页数：1